Clinical Monitoring

Co-produced with industry, patients and public-sector voices, the Patients as Partners events are the only conferences that demonstrate how Pharma can involve patients throughout the entire clinical development life cycle to drive greater efficiencies in clinical research.  The conferences delve into patient engagement ideas, strategies, partnerships, and tools to advance patient participation and achieve better outcomes in trials.

Immuno-Oncology (IO) 360° takes a strategic look at the business and scientific aspects of Immuno-Oncology.  With significant in-put from Lead Advisors Dr. Axel Hoos (former CEO of Scorpion Therapeutics) and Dr. James Gulley (NCI,) the conference examines the current landscape, and reports on the latest advancements in IO to improve and accelerate clinical trials. The audience is comprised of roughly 500 top executives at Pharma companies and Biotechs, as well as the financial community, consultants and leading research organizations in the field of Immuno-Oncology.  

The ESMO Congress is the yearly appointment in Europe for nearly 30,000 clinicians, researchers, oncology nurses, patient advocates, journalists, and representatives of the pharmaceutical industry from all over the world to get together, learn about the latest advances in oncology, and translate science into better cancer patient care. Medical/clinical oncologists, basic translational researchers, oncology nurses, all other oncology professionals, patient advocates, journalists, healthcare industry representatives, policy decision makers, regulators.

The ERS Congress is the once-a-year occasion when the world’s respiratory experts come together, to present and discuss the latest scientific and clinical advances across the entire field of respiratory medicine. It welcomes a global audience of respiratory focused professionals inclusive of clinicians, scientists and researchers, and allied healthcare professionals. As the ERS Congress reaches its 32nd year, we invite you to register for this year’s event – our first to offer both in-person or online attendance.

The Spring Clinical Meetings (SCM) is NKF’s premiere educational event designed for the interprofessional kidney health team. SCM presents a unique opportunity for busy renal health care professionals to explore innovation, research, and best clinical practice within nephrology.

The Association of American Cancer Institutes (AACI) Clinical Research Innovation (CRI) program serves as a network for research leaders to develop and share best practices for the efficient operation of clinical trials offices (CTO) at AACI cancer centers. The programming of the 14th Annual AACI CRI Meeting, “Partnering in Progress,” aligns with CRI’s strategic goal of stimulating cancer center interactions to maximize resources by creating opportunities for peer-to-peer networking and collaboration.